Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy

Clinics

Volumn 65, Issue 3, 2010, Pages 285-290

  Koksal, Hande ^a   Kurban, Sevil ^b  

^a Konya State Hospital   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Arylesterase; Cholecystectomy; Laparoscopy; Oxidative markers; Paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; BIOLOGICAL MARKER; CARBOXYLESTERASE;

ABDOMINAL WALL HERNIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHOLECYSTECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GALLSTONE; GASTROINTESTINAL RADIOGRAPHY; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHIL; NONPARAMETRIC TEST; OXIDATIVE STRESS; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; CHOLECYSTECTOMY, LAPAROSCOPIC; FEMALE; GALLSTONES; HERNIA, VENTRAL; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATIVE STRESS; PNEUMOPERITONEUM, ARTIFICIAL; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 77953490430     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000300008     Document Type: Article

References (39)

1. Kama NA, Kologlu M, Doganay M, Reis E, Atli M, Dolapci M. A risk score for conversion from laparoscopic to open cholecystectomy. Am J Surg. 2001;181:520-5.
2. Sare M, Yilmaz I, Hamamci D, Birincioglu M, Ozmen M, Yesilada O. The effect of carbon dioxide pneumoperitoneum on free radicals. Surg Endosc. 2000;14:649-52.
3. Williams MD, Murr PC. Laparoscopic insufflation of the abdomen depresses cardiopulmonary function. Surg Endosc. 1993;7:12-6.
4. Marathe US, Lilly RE, Silvestry SC, Schauer PR, Davis JW, Pappas TN, et al. Alterations in hemodynamics and left ventricular contractility during carbon dioxide pneumoperitoneum. Surg Endosc. 1996;10:974-8.
5. Kaklamanos IG, Condos S, Merrell RC. Time-related changes in hemodynamic parameters and pressure-derived indices of left ventricular function in a porcine model of prolonged pneumoperitoneum. Surg Endosc. 2000;14:834-8.
6. Dexter SP, Vucevic M, Gibson J, McMahon MJ. Hemodynamic consequences of high- and low-pressure capnoperitoneum during laparoscopic cholecystectomy. Surg Endosc. 1999;13:376-81.
7. Bickel A, Yahalom M, Roguin N, Frankel R, Breslava J, Ivry S, et al. Power spectral analysis of heart rate variability during positive pressure pneumoperitoneum: the significance of increased cardiac sympathetic expression. Surg Endosc 2002;16:1341-4.
8. Eleftheriadis E, Kotzampassi K, Botsios D, Tzartinoglou E, Farmakis H, Dadoukis J. Splanchnic ischemia during laparoscopic cholecystectomy. Surg Endosc. 1996;10: 324-6.
9. Jakimowicz J, Stultiens G, Smulders F. Laparoscopic insufflation of the abdomen reduces portal venous flow. Surg Endosc. 1998;12:129-32.
10. Gudmundsson FF, Gislason HG, Dicko A, Horn A, Viste A, Grong K, et al. Effects of prolonged increased intra-abdominal pressure on gastrointestinal blood flow in pigs. Surg Endosc. 2001;15:854-60.
11. Schilling MK, Redaelli C, Krähenbühl L, Signer C, Büchler MW. Splanchnic microcirculatory changes during CO2 laparoscopy. J Am Coll Surg. 1997;184:378-82.
12. Glantzounis GK, Tselepis AD, Tambaki AP, Trikalinos TA, Manataki AD, Galaris DA, et al. Laparoscopic surgery-induced changes in oxidative stress markers in human plasma. Surg Endosc. 2001;15:1315-9.
13. Seven R, Seven A, Erbil Y, Mercan S, Burçak G. Lipid peroxidation and antioxidant state after laparoscopic and open cholecystectomy. Eur J Surg. 1999;165:871-4.
14. Zulfikaroglu B, Koc M, Soran A, Isman FK, Cinel I. Evaluation of oxidative stress in laparoscopic cholecystectomy. Surg Today. 2002;32:869-74.
15. Polat C, Yilmaz S, Serteser M, Koken T, Kahraman A, Dilek ON. The effect of different intraabdominal pressures on lipid peroxidation and protein oxidation status during laparoscopic cholecystectomy. Surg Endosc. 2003;17:1719-22.
16. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med. 1999;26:892-904.
17. Pasqualini L, Cortese C, Marchesi S, Siepi D, Pirro M, Vaudo G, et al. Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis. 2005;183:349-54.
18. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991;286:152-4.
19. Aviram M. Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radic Biol Med. 2004;37:1301-3.
20. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/ arylesterase polymorphism. Am J Hum Genet 1983;35:1126-38.
21. Kotur-Stevuljevic J, Spasic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Stefanovic A, Vujovic A, et al. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin Biochem. 2008;41:1067-73
22. Aviram M, Rosenblat M. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol. 2005;16:393-9.
23. Nguyen SD, Sok DE. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res. 2003;37:1319-30.
24. Rozenberg O, Aviram M. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun. 2006;351:492-8.
25. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem. 1992;30:391-5.
26. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more s ABTS radical cation. Clin Biochem. 2004;37:277-85.
27. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103-11.
28. Bukan MH, Bukan N, Kaymakcioglu N, Tufan T. Effects of open vs. laparoscopic cholecystectomy on oxidative stress. Tohoku J Exp Med. 2004;202:51-6.
29. Bickel A, Drobot A, Aviram M, Eitan A. Validation and reduction of the oxidative stress following laparoscopic operations: a prospective randomized controlled study. Ann Surg. 2007;246:31-55.
30. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen. Pharmacol. 1998;31:329-36.
31. Canales A, Sanchez-Muniz FJ. Paraoxanase, something more than an enzyme? Med. Clin. (Barc) 2003;121:537-48.
32. Ayub A, Mackness MI, Arrol S, Mackness, Patel BJ, Durrington PN. Serum paraoxonase after myocardial infarction, Arterioscler. Thromb. Vasc. Biol. 1999;19: 330-5.
33. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, et al. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1992;86:193-9.
34. Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia, Atherosclerosis. 2007;191:397-402.
35. Elkiran TE, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer. 2007;7:48.
36. Akcay MN, Polat MF, Yilmaz I, Akcay G. Serum paraoxonase levels in pancreatic cancer, Hepatogastroenterology 2003;50 (Supply 2): ccxxv-ccxxvii.
37. Akcay MN, Polat MF, Yilmaz I, Akcay G. Serum paraoxonase levels in gastric cancer, Hepatogastroenterology 2003b;50 (Supply 2): cclxxiii-cclxxv.
38. Krzystek-Korpacka M, Boehm D, Matusiewicz M, Diakowska D, Grabowski K, Gamian A. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation. Clin Biochem. 2008;41:804-11.
39. Stevens VL, Rodriguez C, Talbot JT, Pavluck MJ, Thun MJ, Calle EE. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort. Prostate. 2008;68:1336-40.